NASDAQ:CYTH
Delisted

Cyclo Therapeutics Stock Predictions

etoro logo Buy CYTH
*Your capital is at risk
$0.721
+0 (+0%)
At Close: Jun 25, 2025
Currently predicting for Mon, 8 Jun 2026

CYTH Prediction Chart

CYTH Predictions History

Latest community submissions for CYTH.
Predictor Target Session Target Price Result Direction Accuracy Score
Feb 18, 2025 $0.93 -4.75% $0.93 V 99.89% 6
Feb 18, 2025 $0.95 -2.97% $0.93 V 98.24% 1
Feb 18, 2025 Bullish $0.93 X 0
Feb 10, 2025 $1.10 -7.31% $0.94 V 82.65% 1
Feb 10, 2025 Bullish $0.94 X 0
Feb 10, 2025 Bullish $0.94 X 0
Feb 10, 2025 $1.70 +120.78% Unrealistic Excluded from avg $0.94 V 19.15% 0
Jul 3, 2023 $1.68 +5.77% $1.63 V 96.83% 1
Jul 3, 2023 $1.65 +3.60% $1.63 V 98.94% 2
Jul 3, 2023 Bullish $1.63 V 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CYTH with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CYCLO THERAPEUTICS, INC.
Cyclo Therapeutics
Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, n...
GOLDEN STAR
Ticker Change Signal Date

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE